Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The biochip market was valued at USD 7.66 Billion in 2025. It is poised to grow at a CAGR of 14.36% during the forecast period of 2026-2035, and reach USD 29.31 Billion by 2035. The market growth is driven by rising demand for rapid diagnostics, increasing prevalence of chronic diseases, advancements in microarray technologies, growing adoption in personalized medicine, and expanding research applications.
Base Year
Historical Period
Forecast Period
In August 2025, ISMO Bio-Photonics advanced organ-on-chip platforms, enabling human-relevant drug testing and accelerating adoption of microfluidic biochip technologies in pharmaceutical research.
In June 2025, the Lab-on-Chip World Congress highlighted commercialization trends, accelerating industry collaboration and expanding adoption of microfluidics-based biochip platforms across diagnostics and biotechnology sectors.
In May 2025, the European Lab-on-Chip Conference fostered collaboration between academia and industry, accelerating innovation and supporting advancements in next-generation microfluidics-based biochip technologies globally.
Compound Annual Growth Rate
14.36%
Value in USD Billion
2026-2035
*this image is indicative*
The market is experiencing steady growth due to increasing demand for high-throughput diagnostics and personalized medicine. Advancements in microarray and lab-on-a-chip technologies are enhancing disease detection and drug discovery processes. The rising prevalence of chronic and infectious diseases is driving adoption across clinical and research settings. Government funding and technological innovation are further supporting market expansion, while integration with AI and data analytics improves efficiency and diagnostic accuracy globally. The market reached a value of approximately USD 7.66 Billion in 2025.
Rising Adoption of Organ-on-Chip Technologies Driving the Market Demand
Growth in the market is driven by increasing demand for advanced in vitro models and precision medicine. For instance, in August 2025, ISMO Bio-Photonics advanced organ-on-chip platforms, enabling human-relevant drug testing and reducing reliance on animal models. This development supports pharmaceutical innovation and accelerates drug discovery processes. Rising investment in microfluidics and lab-on-chip systems continues to strengthen biochip adoption across research and clinical applications globally.
Key trends shaping the market include rising demand for miniaturized diagnostics, increasing microfluidics adoption, technological advancements, expanding applications, and growing investment in research.
Expanding Commercialization of Lab-on-Chip Technologies Shaping the Market Landscape
The market is witnessing strong momentum due to increasing commercialization and industry collaboration. For instance, in June 2025, the Lab-on-Chip World Congress highlighted growing adoption of microfluidics-based platforms across diagnostics and biotechnology. Such events promote partnerships and accelerate technology transfer from research to real-world applications. Advancements in miniaturization and integration are further expanding biochip use in point-of-care testing and personalized healthcare solutions worldwide.
Market Breakup by Technology
Market Breakup by Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
DNA Chips Expected to Lead the Market Segment by Type
The DNA chips segment held the largest revenue share, exceeding 38% during the historical period. Growth is supported by increasing adoption of advanced technologies such as DNA microarray in genomics and disease diagnostics. These tools enable high-throughput analysis and precision medicine applications. Rising research activities and demand for efficient molecular profiling continue to strengthen the segment’s position in the global market.
North America is expected to dominate the market in the historical period, accounting for nearly 48% share. The region benefits from strong technological adoption, including innovations like lab-on-chip platforms that enhance rapid diagnostics. Advanced healthcare infrastructure, growing biotechnology investments, and increasing demand for point-of-care solutions continue to drive regional growth, reinforcing North America’s leadership in the global industry.
The key features of the market report comprise patent analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Abbott Laboratories Inc., headquartered in Abbott Park, Illinois, was founded in 1888. The company is a global healthcare leader with a strong presence in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. In the biochip market, Abbott focuses on advanced diagnostic solutions, including technologies such as biosensor platforms, enabling rapid and accurate disease detection. Its diversified portfolio supports point-of-care testing and laboratory-based diagnostics worldwide.
Agilent Technologies, Inc., headquartered in Santa Clara, California, was established in 1999 as a spin-off from Hewlett-Packard. The company specializes in life sciences, diagnostics, and applied chemical markets. In the biochip space, Agilent offers advanced genomic and proteomic solutions, including DNA microarray technologies for gene analysis. Its portfolio supports research, clinical diagnostics, and pharmaceutical development, strengthening its position in precision medicine and molecular biology applications globally.
PerkinElmer Inc., headquartered in Waltham, Massachusetts, was founded in 1937 and operates as a global leader in diagnostics and life sciences. The company provides solutions across genomics, imaging, and laboratory services. Within the biochip market, PerkinElmer supports advanced screening technologies, including ELISA chip platforms, enhancing biomarker detection and disease analysis. Its offerings cater to pharmaceutical, clinical, and research laboratories, driving innovation in diagnostics and drug discovery.
Fluidigm Corporation, headquartered in South San Francisco, California, was founded in 1999 and focuses on life science tools and integrated fluidic systems. The company is recognized for its expertise in single-cell analysis and genomics. In the biochip market, Fluidigm develops innovative microfluidics chip technologies that enable precise sample handling and high-throughput analysis. Its solutions support research institutions and biopharmaceutical companies in advancing molecular and cellular studies.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, BioMérieux SA, HORIBA, Ltd., QIAGEN N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., and Cepheid (Danaher Corporation).
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share